JENNIFER WHITEHEAD: Open Payments
NPI 1942933049 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,694 in 18 payments from 8 companies in 2025. Trend: 2023 $665 · 2024 $1,723 · 2025 $1,694
Food & beverage: $1,694
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $935 |
| Novo Nordisk Inc | 3 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $122 |
| Lilly USA, LLC | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 1 | $105 |
| ABBVIE INC. | 2 | $38 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: BREZTRI, AIRSUPRA, Ozempic, CAPLYTA, BIJUVA, ZEPBOUND, VOQUEZNA, FARXIGA.
Industry payments across FL — which companies pay providers there.
